+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Calcitonin and diphosphonate in the treatment of Paget's disease of bone



Calcitonin and diphosphonate in the treatment of Paget's disease of bone



Metabolic Bone Disease and Related Research 3(4-5): 317-326



The ideal treatment for Paget's disease of bone should control turnover irrespective of its initial activity and produce a sustained remission once treatment is withdrawn. Unfortunately, neither the calcitonins nor the diphosphonates currently available entirely fulfil these requirements. Preliminary studies suggest that combinations of calcitonin and EHDP produce significantly better responses than those of the individual agents alone. This proposition is examined critically in terms of the optimum effects achieved with calcitonin and EHDP alone paying particular attention to variables such as disease activity, dose and duration of treatment.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042432520

Download citation: RISBibTeXText

PMID: 6820113


Related references

Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP. Schweizerische Medizinische Wochenschrift 111(49): 1893-1897, 1981

Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment. Radiology 125(3): 761-764, 1977

Paradoxical acute hypercalcemic effect of salmon calcitonin in patients having Paget's disease of bone after treatment with dichloromethylene diphosphonate. Hormone and Metabolic Research 16(5): 258-261, 1984

Paget's bone disease treated with diphosphonate and calcitonin. Lancet 1(7960): 615-617, 1976

Combined diphosphonate and calcitonin therapy for Paget's disease of bone. Calcified Tissue Research 21 Suppl: 321-326, 1976

Bone scintigraphy in Paget's disease treated with combined calcitonin and diphosphonate (EHDP). Metabolic Bone Disease and Related Research 4(2): 103-111, 1982

Diphosphonate Treatment of Paget's Disease of Bone. Hormone and Metabolic Research 6(01): 62-69, 1974

Aminohexane diphosphonate in the treatment of Paget's disease of bone. Journal of Bone and Mineral Research 2(4): 273-279, 1987

The diphosphonate space: a useful quantitative index of disease activity in patients undergoing hydroxy methylene diphosphonate (HMDP) bone imaging for Paget's disease [corrected. European Journal of Nuclear Medicine 18(9): 757-759, 1991

Paget's disease of bone--clinical evaluation and treatment with diphosphonate. Australian and New Zealand Journal of Medicine 9(1): 31-35, 1979

Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment. Quarterly Journal of Medicine 42(166): 235-256, 1973

Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage. La Nouvelle Presse Medicale 9(45): 3429-3433, 1980

Treatment of Paget's disease of bone with disodium ethane-1-hydroxy-1,1-diphosphonate. Journal of Endocrinology 64(3): 51p, 1975

Treatment of Paget's disease of bone with ethane-1, hydroxy-1,1 diphosphonate (EHDP) at a low dosage (5 mg/kg/day). Clinical Orthopaedics and Related Research 1983(174): 193-205, 1983

An evaluation of serum osteocalcin in paget's disease on bone and its response to diphosphonate treatment. Arthritis and Rheumatism 31(9): 1142-1147, 1988